Sponsored by

xCures

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 5076 to 5100 of about 5880

Previous 25

Website Changes

12/12/2004

NHS refuses to pay for cancer drug which could extend man`s life

12/09/2004

12/09/2004

Continuous low-dose chemotherapy plus inhibition of cyclooxygenase-2 as an antiangiogenic therapy of glioblastoma multiforme

12/09/2004

Allos Therapeutics (ALTH) stock leapt 37 percent in afternoon action.

12/08/2004

Press Release Source: DaimlerChrysler Services North America

12/07/2004

TransMolecular Successfully Completes Phase I/II Clinical Trial With its Targeted Oncology Therapeutic

12/06/2004

Second-Line Chemotherapy With Irinotecan Plus Carmustine in Glioblastoma Recurrent or Progressive After First-Line Temozolomide Chemotherapy: A Phase II Study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).

12/06/2004

Protein Upped Immune Cells, Slowed Growth of Glioblastoma Multiforme

12/06/2004

Fighting Cancerous Cells

12/06/2004

Silencing of Monocarboxylate Transporters via Small Interfering Ribonucleic Acid Inhibits Glycolysis and Induces Cell Death in Malignant Glioma: An in Vitro Study.

12/06/2004

Display of hats meant to increase awareness of brain tumors

12/02/2004

Methylphenidate improves attention, behavior of children surviving leukemia, brain tumors

12/02/2004

Study finds no greater risk of brain tumors due to cell phones

12/01/2004

Ark Facility Receives GMP Certification and Approval to Manufacture Cerepro

12/01/2004

Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children.

12/01/2004

YM BioSciences Drug Is Given Orphan Status

11/30/2004

The large international clinical trial involving the drug Edotecarin was closed and all listing for it were removed from the website.

11/28/2004

Updated the About Us page to give more history of the organization

11/27/2004

Added a presentation on Acoustic Neuromas by Dr Michael Schulder

11/25/2004

Reduced immunoglobulin E and allergy among adults with glioma compared with controls.

11/25/2004

Role of synaptojanin 2 in glioma cell migration and invasion.

11/25/2004

SHP-2-dependent mitogen-activated protein kinase activation regulates EGFRvIII but not wild-type epidermal growth factor receptor phosphorylation and glioblastoma cell survival.

11/25/2004

White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor.

11/25/2004

Invasive phenotype observed in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant sublines of 9L rat glioma cells: a tumor model mimicking a recurrent malignant glioma.

11/25/2004

Isotron licenses ORNL cancer treatment technology

Our privacy / cookie policy has changed.
Click HERE to read it!